gangrene?

Gangrene is the death of living tissue caused either by interruption of blood supply or by invasion and toxin production of gas-forming bacteria, most often Clostridium perfringens. It manifests in two forms: dry gangrene, in which tissue blackens and mummifies from loss of circulation alone, and wet gangrene, in which bacterial toxins cause rapid putrefaction, systemic poisoning, and tissue dissolution. Wet gangrene is the more dangerous variant, capable of spreading through healthy tissue at a rate of centimetres per hour, and it is the form that defined surgical risk and shaped medical practice throughout the twentieth century.

In the era before systemic antibacterial treatment became feasible, the distinction mattered absolutely. Dry gangrene, advancing slowly, could be managed by conservative waiting: the line of demarcation between dead and living tissue would clarify over days or weeks, allowing clean amputation at a safe margin. Wet gangrene admitted no such mercy. It produced profound septic shock through bacterial toxins flooding the bloodstream. The only defence available to surgery was speed and radicalness: amputation well above the visible infection, leaving no margin for doubt, and even then survival was far from assured.

The 1943 Sicily campaign, the first large-scale Allied amphibious operation of the Second World War, revealed the full catastrophe of this condition when reliable systemic antibacterial treatment did not exist. Invasion casualties arrived at field hospitals with contaminated wounds: shrapnel wounds packed with soil, seawater, and fabric fragments from uniforms and landing craft. The standard response—cleaning, dressing, and hoping—proved insufficient. Wet gangrene developed in a fraction of wounded within forty-eight hours. The Geneva Sanitary Bureau would later document that gangrene mortality in Sicily reached 18 percent of all wounded men, compared to historical records from the same theatre suggesting rates near 1 percent when systemic treatment had been available.

The absence of reliable systemic antibacterial drugs meant that surgery could not bank on killing bacteria once they were established in tissue. The azo drugs, the only available class of systemic antibacterial compounds, proved ineffective against Clostridium and other anaerobic gas-forming bacteria that thrived in traumatic wounds. Even the most modern sulfonamide therapy failed to clear bacterial toxins from the bloodstream faster than amputation could remove the infected limb. Field surgeons were forced to choose: amputate early and aggressively, or watch men die of septic shock within days as toxins accumulated faster than any chemical treatment could neutralize them.

This pattern persisted through the post-war period, driving the development of asepsis maximalism as medical doctrine. If bacterial infection could not be reliably cured once established, it had to be prevented from establishing at all. Surgical protocol hardened around the avoidance of any contamination whatsoever. Clean wards developed segregated operating theatres with positive-pressure air filtration. Instruments were steam-sterilized at higher temperatures and longer exposures than pre-war practice. Surgical teams wore multiple layers of disposable covering. The goal was not to control gangrene after the fact, but to prevent the wound contamination that would produce it.

Even with these precautions, gangrene remained common. A clean ward could prevent obvious contamination but could not eliminate the bacteria already present in a patient's own skin and mucosal surfaces. Minor surgical sites—even a routine appendectomy—carried visible risk of subsequent infection and tissue death. The mortality rate in elective abdominal surgery during the 1950s remained approximately 3 percent from sepsis and gangrene, a figure that would have been considered unacceptable in any era with systemic antibacterial treatment. Trauma and crush injuries remained substantially worse: crush syndrome from industrial accidents or vehicle collision, in which muscle tissue died from pressure ischemia, frequently developed wet gangrene in the days following injury and resulted in amputation or death in more than half of cases.

Serum therapy, developed and refined through the 1970s and 1980s, offered some improvement. Hyperimmune serum produced in specialized serum farms could neutralize bacterial toxins more rapidly than azo drug therapy alone. The Halloway-Umezaki method combined passive antibody injection with more aggressive surgical debridement, removing all visibly compromised tissue and relying on the immune serum to manage toxaemia while amputation proceeded. This approach reduced mortality in established gangrene from approximately 40 percent to roughly 25 percent by the 1990s, a significant gain but one still far distant from the pre-1928 baseline.

Gangrene persists as a common surgical complication into the present day, particularly in peripheral vascular disease and diabetic infection. The economic and social cost remains enormous: amputation from gangrene represents one of the largest categories of permanent disability in industrialized nations, and the prolonged hospital stays required to manage infected wounds consume substantial portions of hospital budgets in systems built entirely around infection prevention rather than cure.